Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
- PMID: 32398378
- PMCID: PMC7293636
- DOI: 10.1073/pnas.2006691117
Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
Conflict of interest statement
The authors declare no competing interest.
Comment in
-
Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12529-12530. doi: 10.1073/pnas.2007408117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398377 Free PMC article. No abstract available.
Comment on
-
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6. Proc Natl Acad Sci U S A. 2020. PMID: 32253318 Free PMC article.
References
-
- Fortenberry J. D., et al. ; Thrombocytopenia-Associated Multiple Organ Failure (TAMOF) Network Study Group , Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: The thrombocytopenia-associated multiple organ failure network prospective experience. Crit. Care Med. 47, e173–e181 (2019). - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
